LIBROS
Njeh CF, Han D, Fuerst T, eds: Quantitative ultrasound: Assessment of osteoporosis and bone status. London: Martin Duntz, 1999.
Henderson JE, Goltman D, eds. The Osteoporosis Primer. Cambridge: Cambridge University Press, 2000.
Body JJ, ed. Tumor bone diseases and osteoporosis in cancer patients: Pathophysiology, diagnosis and therapy. New York: Marcel Dekker, 2000.
Kova KJ, Zuckermann JD, eds. Hip fractures: A practical guide to management. New York: Springer, 2000.
NÚMEROS MONOGRÁFICOS
Cabero A, ed. Los SERM en la THS. Folia Clin Obst Ginecol 2000; 21: 1-73.
Mundy G, Lipton A, Singre FR, eds. Second North American Symposium on Skeletal Complications of Malignancy. Cancer 2000; 88: 2.891-3.088.
NUESTROS AUTORES
Ballabriga A. Morphological and physiological changes during growth: an update. Eur J Clin Nutr 2000; 54 (Suppl 1):
S1-6.
Martínez G, Hawkins F. Atenuación ultrasónica del calcáneo: precisión y correlación con la absorciometría doble de rayos X lumbar y de antebrazo. Endocrin Nutr 2000; 47: 103-107.
Roig-Vilaseca D, Nolla JM, Roig-Escofet D. Suitability of the T-score for establishing bone mineral density categories. Osteoporosis Int 2000; 11: 408-410.
Campos MM, López PJ, Escobar F, et al. Intensive insulin therapy and bone mineral density type 1 diabetes mellitus: a prospective study. Osteoporosis Int 2000; 11: 455-459.
Rodríguez A, Martin G, Vázquez M, et al. Estimación del riesgo de fracturas osteoporóticas mediante medición ultrasónica del hueso. Rev Clin Esp 2000; 200: 193-202.
Peris P. Densitometría ósea, 2000. Med Clin (Barc) 2000; 114: 540-542.
Álvarez L, Ricós C, Peris P, et al. Components of biological variation of biochemical markers of bone turnover in Paget's bone disease. Bone 2000; 26: 571-576.
Díaz C, Rodríguez A, Naves ML, et al. Marcadores metabólicos óseos y uso de la vitamina D en diálisis. Encuesta multicéntrica (II). Nefrología 2000; 20: 244-253.
Díaz B, Gómez C. Los bisfosfonatos en el tratamiento de la osteoporosis. Rev Clin Esp 2000; 200: 327-329.
Guañabens N. Osteoporosis y transplante de órganos sólidos. Med Clin (Bar) 2000; 114: 772-773.
Vallecillo G, Díez A, Carbonell J, González Macías J. Tratamiento de la osteoporosis con calcio y vitamina D. Med Clin (Barc) 2000; 115: 46-51.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
Manologas SC. Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res 2000; 15: 1.001-1.005.
Szulc P, Seeman E, Delmas PD. Biochemical measurements of bone turnover in children and adolescents. Osteoporosis Int 2000; 11: 281-294.
Nguyen TV, Eisman JA. Genetics of fracture: challanges and opportunities. J Bone Miner Res 2000; 15: 1.253-1.256.
Miller PD. Controversies in bone mineral density diagnostic classifications. Calcif Tissue Int 2000; 66: 317-319.
Riggs BL. Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients? Bone 2000; 26: 551-552.
Editorial. Warfarin use and fracture risk. Nutr Rev 2000; 58: 20-29.
Basaria S, Dobs AS. Risks versus benefits of testosterone therapy in elderly men. Drugs Ageing 2000; 15: 131-142.
Vermeulen A. Andropause. Maturitas 2000; 34: 5-15.
Stewart A, Reid DM. Quantitative ultrasound or clinical risk factors-which best identifies women at risk of osteoporosis? Br J Radiol 2000; 73: 165-171.
Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in celiac disease and inflammatory bowell disease. Gut 2000; 46 (Suppl 1): 1-8.
Shaywitz BA, Shaywitz SE. Estrogen and Alzheimer disease - Plausible theory, negative clinical trial. JAMA 2000; 283: 1.055-1.056.
Pfeifer M, Minne HW. Vitamin D and hip fracture. Trends Endocrinol Metab 2000; 10: 417-420.
Major PP, Lipton A, Berenson A, et al. Oral bisphosphonates-a review of clinical use in patients with bone metastases. Cancer 2000; 88: 6-14.
Levenson ASW, Jordan VC. Selective estrogen receptor modulation: molecular pharmacology for the millenium. Eur J Cancer 2000; 35: 1.628-1.639.
Kanis JA, Torgerson D, Cooper C. Comparison of the European and USA practice guidelines for osteoporosis. Trends Endocrinol Metab 2000; 11: 28-32.
Hill I, Fasano A, Schwartz R, et al. The prevalence of celiac disease in at-risk groups of children in the United States. Pediatr 2000; 136: 86-90.
Heathcote EJ. Management of primary biliary cirrhosis. Hepatology 2000; 31: 1.005-1.013.
Heaney RP. There should be a dietary guideline for calcium. Am J Clin Nutr 2000; 71: 658-661.
Ellis KJ. Human body composition. Physiol Rev 2000; 80: 650-671.
OTROS ARTICULOS DE INTERÉS
Schulte C, Beelen DW, Schaefer UW. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporosis Int 2000; 11: 344-353.
Van Staa TP, Leufkens HGM, Abenhaim L, et al. Use of corticosteroid and risk of fractures. J Bone Miner Res 2000; 15: 993-1.000.
Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamina D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000; 15: 1.113-1.118.
Cardon JR, Garner C, Bennett ST, et al. Evidence for a major gene for bone mineral density in idiopathic osteoporotic families. J Bone Miner Res 2000; 15: 1.132-1.137.
Langdahl BL, Gravholt CH, Brixen K, Eriksen EF. Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur J Clin Invest 2000; 30: 608-617.
Yoshimura M. Analgesic mechanism of calcitonin. J Bone Miner Metab 2000; 18: 230-233.
Phillips AJ, Ostiere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporosis Int 2000; 11: 449-454.
Randell AG, Nguyen TV, Bhalerao N, et al. Deterioration in quality of life following hip fracture: a prospective study. Osteoporosis Int 2000; 11: 460-466.
Lane NE, Sánchez S, Genant HK, et al. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporosis Int 2000; 11: 4.
Cradon LR, Garner C, Bennett ST, et al. Evidence for a major gene for bone mineral density in idiopathic osteoporotic families. J Bone Miner Res 2000; 15: 1.132-1.137.
Haleen JM, Alatalo SL, Suominen H, et al. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000; 15: 1.337-1.345.
Hocking L, Slee F, Haslam SI, et al. Familial Paget's disease of bone: Patterns of inheritance and frequency of linkage to chromosome 18q. Bone 2000; 26: 577-580.
Center JR, Nguyen TV, Sambrook PN, et al. Hormonal and biochemical parameters and osteoporosis fractures in elderly men. J Bone Miner Res 2000; 15: 1.405-1.411.
Zmuda JM, Cauley JA, Glynn NW, Finkelstein JS. Posterior-anterior and lateral dual-energy x-ray absorptiometry fo the assessment of vertebral osteoporosis and bone loss among older men. J Bone Miner Res 2000; 15: 1.417-1.424.
Bjarnason NH, Christiansen C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 2000; 26: 561-570.
Barkman R, Kantorovich E, Singal C, et al. A new method for quantitative ultrasound measurements at multiple skeletal sites. J Clin Densitometry 2000; 3: 1-7.
Zamora SA, Rizzoli R, Belli DC, et al. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepuberal girls. J Clin Endocrinol Metab 2000; 84: 4.541-4.544.
Barrett-Connor E, Mueller JE, von Muhlen DG, et al. Low levels of estradiol are associated with vertebral fractures in older men, but not in women. J Clin Endocrinol Metab 2000; 85: 219-233.
CONSULTANTES DEL VOLUMEN 9
El Comité Editorial de REVISTA ESPAÑOLA DE ENFERMEDADES METABÓLICAS ÓSEAS agradece la ayuda recibida para la crítica de los trabajos enviados durante el 2000 a los siguientes consultantes:
J. Blanch
M. Díaz Curiel
J. B. Díaz López
E. Fernández Villoria
J. Gijón Baños
F. Hawkins Carranza
A. Morales Piga
C. de la Piedra
A. Torrijos Eslava
J. C. Vallejo Galbete